Utility of Napsin A and Thyroid Transcription Factor 1 in Differentiating Metastatic Pulmonary from Non-Pulmonary Adenocarcinoma in Pleural Effusion
- 27 April 2011
- journal article
- research article
- Published by S. Karger AG in Acta Cytologica
- Vol. 55 (3), 266-270
- https://doi.org/10.1159/000326954
Abstract
Objective: It was our aim to evaluate the usefulness of napsin A and thyroid transcription factor 1 (TTF-1) in the differential diagnosis of metastatic pulmonary and non-pulmonary adenocarcinomas (ACs) in pleural effusion. Study Design: A total of 84 pleural effusion fluid cell blocks were collected from metastatic ACs. There were 53 pulmonary ACs and 31 non-pulmonary ACs. Immunohistochemical staining was performed with antibodies against napsin A and TTF-1. Results: Napsin A was positive in 44/53 (83%) cases of pulmonary ACs, and TTF-1 was positive in 30/53 (57%) cases of pulmonary ACs. All non-pulmonary ACs were negative for napsin A and TTF-1. Napsin A showed a reactivity in >75% of the tumor cells in 36 of the 44 positive cases (82%), whereas TTF-1 showed a reactivity in >75% of the tumor cells only in 6 of the 30 positive cases (20%; p < 0.01). Poorly differentiated pulmonary ACs expressed napsin A (73%) more frequently than TTF-1 (53%), but this was not statistically significant (p = 0.45). Conclusion: We conclude that napsin A is superior to TTF-1 with regard to distinguishing between metastatic pulmonary and non-pulmonary ACs in cell blocks prepared from malignant pleural effusions.Keywords
This publication has 9 references indexed in Scilit:
- The utility of napsin‐A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomasCancer Cytopathology, 2010
- A study of immunohistochemical differential expression in pulmonary and mammary carcinomasLaboratory Investigation, 2010
- Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesotheliomaHuman Pathology, 2010
- Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocksDiagnostic Cytopathology, 2009
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco ControlJNCI Journal of the National Cancer Institute, 2008
- Napsin A (TA02) is a useful alternative to thyroid transcription factor‐1 (TTF‐1) for the identification of pulmonary adenocarcinoma cells in pleural effusionsDiagnostic Cytopathology, 2007
- Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organsPathology - Research and Practice, 2005
- Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinomaBritish Journal of Cancer, 2003
- Thyroid transcription factor 1Cancer, 2002